Stay updated on Fruquintinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA notice about NIH’s terminology transition appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study record itself still displays a 403 error.SummaryDifference1%

- Check28 days agoChange DetectedThe ClinicalTrials.gov site revision identifier in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check42 days agoChange DetectedThe study record page now shows a 403 Forbidden error instead of the study details, replacing the content with a standard error page.SummaryDifference21%

- Check49 days agoChange DetectedThe revision label on the page updated from v3.6.6 to v3.7.0, indicating a newer page revision. This reflects an update to the document/versioning rather than to the study data.SummaryDifference0.0%

- Check63 days agoChange DetectedA new site revision number appears as v3.6.6, replacing the previous v3.6.5.SummaryDifference0.0%

Stay in the know with updates to Fruquintinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.